2m 2m 2m 2m 2m 2m 2m
RHYTHM PHARM (RYTM)
NASDAQ
$106.31+$4.92 (+4.85%)
Price as of Jun 23, 2026 6:36 PM EDT- $7.0BMarket Cap
- 63.19%1-Year Change
- BiotechnologyIndustry
RHYTHM PHARM (RYTM)
$106.31+$4.92 (+4.85%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 194.8M +49.68% | 130.1M +68.06% | 77.4M +227.56% | 23.6M +649.46% | |
Cost of Revenue | 19.5M +45.81% | 13.4M +43.71% | 9.3M +336.10% | 2.1M +256.09% | |
Gross Profit | 175.3M +50.12% | 116.8M +71.39% | 68.1M +216.79% | 21.5M +741.68% | |
Sales and Marketing Expense | 194.9M +35.09% | 144.3M +22.78% | 117.5M +27.71% | 92.0M +34.38% | |
Research and Development Expense | -167.3M -29.68% | -238.0M +76.33% | -135.0M +24.23% | -108.6M +4.32% | |
Depreciation and Amortization Expense | 900,000 +5.26% | 855,000 0.00% | 855,000 +10.47% | 774,000 +126.32% | |
Total Operating Expenses | 381.8M -3.50% | 395.6M +51.13% | 261.8M +29.09% | 202.8M +17.08% | |
Operating Profit | -192.0M -27.68% | -265.5M +44.02% | -184.4M +2.90% | -179.2M +5.35% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -5.3M -10.23% | -5.9M -57.58% | -13.9M +167.10% | -5.2M N/A | |
Interest Income and Expense and Net | -5.3M -10.23% | -5.9M -57.58% | -13.9M +167.10% | -5.2M -1,263.53% | |
Total Nonoperating Income and Expense | -4.0M -176.73% | 5.2M +2,059.26% | 243,000 +112.39% | -2.0M -101.95% | |
Income before Taxes | -196.0M -24.67% | -260.3M +41.36% | -184.1M +2.77% | -179.2M +5.35% | |
Income Taxes | 497,000 +43.64% | 346,000 -38.65% | 564,000 N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -196.5M -24.58% | -260.6M +41.11% | -184.7M +1.97% | -181.1M +160.18% | |
Net Income from Continuing Operations Applicable to Common | -201.9M -23.68% | -264.6M +43.70% | -184.1M +1.65% | -181.1M +160.18% | |
Basic EPS and Net Income | -3.11 -28.34% | -4.34 +35.63% | -3.20 -7.78% | -3.47 +147.86% | |
Diluted EPS and Net Income | -3.11 -28.34% | -4.34 +35.63% | -3.20 -7.78% | -3.47 +147.86% | |
Basic Weighted Average Shares | 65.0M +6.54% | 61.0M +5.76% | 57.7M +10.65% | 52.1M +5.08% | |
Diluted Weighted Average Shares | 65.0M +6.54% | 61.0M +5.76% | 57.7M +10.65% | 52.1M +5.08% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 54.3M -39.08% | 89.1M +48.36% | 60.1M -52.94% | 127.7M +115.50% | |
Short-Term Investments | 334.6M +44.60% | 231.4M +7.26% | 215.8M +4.94% | 205.6M -12.73% | |
Cash and Cash Equivalents and Short-Term Investments | 388.9M +21.33% | 320.6M +16.21% | 275.8M -17.23% | 333.3M +13.03% | |
Total Current Assets | 466.9M +24.78% | 374.2M +21.39% | 308.3M -12.98% | 354.2M +14.87% | |
Accumulated Depreciation | 5.2M +10.11% | 4.8M +17.44% | 4.1M +28.65% | 3.2M +39.73% | |
Property and Plant and Equipment and Net | 1.1M +74.68% | 632,000 -52.87% | 1.3M -38.96% | 2.2M -21.90% | |
Total Long-Term Assets | 1.1M +74.68% | 632,000 -52.87% | 1.3M -38.96% | 2.2M -21.90% | |
Total Assets | 480.2M +22.41% | 392.3M +17.89% | 332.7M -13.00% | 382.5M +16.07% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 7.3M +373.46% | 1.5M N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 105.9M -8.29% | 115.5M +109.26% | 55.2M +38.67% | 39.8M -8.33% | |
Total Long-Term Debt | 100.9M -6.82% | 108.3M N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 104.2M -8.05% | 113.4M +5.17% | 107.8M +37.46% | 78.4M +2,973.70% | |
Total Liabilities | 210.2M -7.71% | 227.7M +39.72% | 163.0M +37.87% | 118.2M +160.55% | |
Retained Earnings | -1.4B +17.01% | -1.2B +29.13% | -894.7M +26.01% | -710.1M +34.24% | |
Total Stockholders Equity | 139.1M +540.02% | 21.7M -87.20% | 169.8M -35.76% | 264.3M -7.00% | |
Total Shares Outstanding | 67.2M +7.72% | 62.4M +4.99% | 59.4M +4.97% | 56.6M +12.59% | |
Cash Flow | |||||
Cash from Operating Activities | -115.7M +1.58% | -113.9M -16.36% | -136.2M -21.49% | -173.4M +18.78% | |
Capital Expenditures | 953,000 +1,927.66% | 47,000 0.00% | 47,000 -83.27% | 281,000 -35.25% | |
Cash from Investing Activities | -137.2M +184.71% | -48.2M +750.36% | -5.7M -120.21% | 28.0M +145.09% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 218.0M +13.97% | 191.2M +157.16% | 74.4M -65.22% | 213.8M +28.44% | |
Financials Ratio | |||||
Gross Margin | 89.99% +0.30% | 89.73% +1.98% | 87.99% -3.29% | 90.98% +12.31% | |
Operating Margin | -98.59% -51.68% | -204.04% -14.31% | -238.10% -68.58% | -757.92% -85.94% | |
Return on Assets | -45.05% -37.33% | -71.89% +39.21% | -51.64% +1.51% | -50.88% +88.78% | |
Return on Equity | -244.45% -10.19% | -272.19% +219.84% | -85.10% +28.84% | -66.05% +113.82% | |
Revenue Growth | 49.68% -27.01% | 68.06% -70.09% | 227.56% -64.96% | 649.46% N/A | |
Current Ratio | 4.41 +36.05% | 3.24 -41.99% | 5.58 -37.24% | 8.90 +25.31% | |
Cash Ratio | 0.51 -33.57% | 0.77 -29.11% | 1.09 -66.06% | 3.21 +135.08% | |
Debt-to-Equity Ratio | 0.78 -84.61% | 5.05 N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.23 -19.51% | 0.28 N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow